Society Association of Victims of Agent Orange/Dioxin aims for progress and innovation in 2023-2028 term
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.
Bora Pharmaceuticals Exits Integration Phase with Sequentially-Improved Gross and Operating Margins 5.